CIK 0001709941
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474721157
- Phone
- +1 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- 4 Open-market buy Former 10% Owner bought 450,000 shares at $18.00 ($8,100,000)
- 4 Open-market buy Director bought 900,000 shares at $18.00 ($16,200,000)
- 4 Open-market buy Director bought 400,000 shares at $18.00 ($7,200,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 666,665 shares at $18.00 ($11,999,970)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 4 · 61 filings